“It’s a huge undertaking, and I am delighted to announce that the life sciences team is now ready to graduate from our X lab and become a standalone Alphabet company, with Andy Conrad as CEO“, Brin said.
Advertisement
Alphabet President Sergey Brin, co-founder of Google and previous director of Google X, announced the Life Sciences’ division’s graduation.
The team will be continuing their motivated and innovative work along with other life science companies, by moving concept technologies into reality, from R&D to clinical trials.
A legal dispute is unlikely since Google made clear in its announcement on Monday that in creating a parent company called Alphabet Inc, it was not intending to build products and brands under that name.
With the separate company formation operating on different dynamics than a unit under Google, Conrad will be able to push the Life Sciences Company to new avenues and even achieve far-fetched moonshot projects which were not feasible under the old organization hierarchy.
Brin noted that Google X first undertook to “put computing inside a contact lens” starting three years ago.
The health-focused team, which had been part of Google’s X Labs, has become known for a focus on battling ailments associated with the aging process.
The new life sciences company includes programmers, as well as people skilled in optics and oncology, Brin wrote.
This move isn’t that odd as Alphabet starts to take the divisions that make more sense under that umbrella from under the Google umbrella. “The efforts it has spawned include a nanodiagnostics platform, a cardiac and activity monitor, and the Baseline Study”, he explains.
And it’s precisely where it seems to be going, with a gathered diverse team of oncologists, engineers and other experts, who will hopefully work together and design better prospects for patients worldwide.
Advertisement
BMW’s Alphabet, which provides services to companies with vehicle fleets, operates in 18 countries and supplies 530,000 vehicles to corporate customers.
